Literature DB >> 10432709

Antiviral nucleoside drug delivery via amino acid phosphoramidates.

C R Wagner1, S L Chang, G W Griesgraber, H Song, E J McIntee, C L Zimmerman.   

Abstract

Stable and water soluble amino acid phosphomonoester amidates of AZT were synthesized and shown to have potent anti-HIV-1 activity. Intracellular and cell extract metabolism studies revealed that these compounds are likely to be enzymatically converted to the corresponding monophosphates. In addition, we have shown that the half life and tissue distribution of a phosphoramidate of AZT is 5 and 10-fold greater, respectively, than AZT.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10432709     DOI: 10.1080/15257779908041599

Source DB:  PubMed          Journal:  Nucleosides Nucleotides        ISSN: 0732-8311


  7 in total

Review 1.  Synthesis of nucleoside phosphate and phosphonate prodrugs.

Authors:  Ugo Pradere; Ethel C Garnier-Amblard; Steven J Coats; Franck Amblard; Raymond F Schinazi
Journal:  Chem Rev       Date:  2014-08-21       Impact factor: 60.622

2.  Pharmacokinetics of amino acid phosphoramidate monoesters of zidovudine in rats.

Authors:  Heng Song; George W Griesgraber; Carston R Wagner; Cheryl L Zimmerman
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation.

Authors:  Brahma Ghosh; Alexey O Benyumov; Phalguni Ghosh; Yan Jia; Svetlana Avdulov; Peter S Dahlberg; Mark Peterson; Karen Smith; Vitaly A Polunovsky; Peter B Bitterman; Carston R Wagner
Journal:  ACS Chem Biol       Date:  2009-05-15       Impact factor: 5.100

4.  Treatment of breast and lung cancer cells with a N-7 benzyl guanosine monophosphate tryptamine phosphoramidate pronucleotide (4Ei-1) results in chemosensitization to gemcitabine and induced eIF4E proteasomal degradation.

Authors:  Shui Li; Yan Jia; Blake Jacobson; Joel McCauley; Robert Kratzke; Peter B Bitterman; Carston R Wagner
Journal:  Mol Pharm       Date:  2013-02-04       Impact factor: 4.939

Review 5.  Attacking a nexus of the oncogenic circuitry by reversing aberrant eIF4F-mediated translation.

Authors:  Peter B Bitterman; Vitaly A Polunovsky
Journal:  Mol Cancer Ther       Date:  2012-05       Impact factor: 6.261

Review 6.  Cap-dependent translation initiation factor eIF4E: an emerging anticancer drug target.

Authors:  Yan Jia; Vitaly Polunovsky; Peter B Bitterman; Carston R Wagner
Journal:  Med Res Rev       Date:  2012-04-11       Impact factor: 12.944

Review 7.  H-Phosphonate Chemistry in the Synthesis of Electrically Neutral and Charged Antiviral and Anticancer Pronucleotides.

Authors:  Adam Kraszewski; Michal Sobkowski; Jacek Stawinski
Journal:  Front Chem       Date:  2020-11-13       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.